Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Emmaus Life Sciences, Inc. (EMMA) had Weighted-Average Shares Outstanding (Diluted) of 70.19M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.98M |
|
$-3.33M |
|
$0.17M |
|
$1.81M |
|
$2.81M |
|
$-0.82M |
|
$-2.51M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-0.82M |
|
$-0.64M |
|
70.19M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
70.19M |
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$6.00M |
|
$0.10M |
|
$12.70M |
|
$18.70M |
|
$70.54M |
|
$2.28M |
|
$16.02M |
|
$86.56M |
|
$-67.86M |
|
$-67.86M |
|
$-67.86M |
|
70.19M |
|
| Cash Flow Statement Financials | |
$-0.34M |
|
-- |
|
$-0.70M |
|
$2.13M |
|
$1.07M |
|
$-1.05M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.09 |
|
-- |
|
-- |
|
-0.03 |
|
-0.45 |
|
91.52% |
|
-41.52% |
|
-41.52% |
|
-- |
|
-168.06% |
|
-168.26% |
|
$-0.34M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.09 |
|
0.97 |
|
93.00 |
|
4.91% |
|
4.91% |
|
-17.84% |
|
5.09% |
|
$-0.97 |
|
$-0.00 |
|
$-0.00 |
|